|
| Friday, October 8, 2021 |
|
|
君联资本领投丰凯医疗B轮融资 |
| 近日，坐落于上海张江国际医学园区的微创伤循环辅助器械平台企业丰凯医疗（以下简称“丰凯”）完成了B轮融资。本轮融资由君联资本领投，跟投方包括辰德资本、赛富基金、成为创伴以及凯风创投，老股东礼来亚洲基金、开泰投资持续加码。 more info >> |
|
|
君聯資本領投豐凱醫療B輪融資 |
| 近日，坐落於上海張江國際醫學園區的微創傷循環輔助器械平台企業豐凱醫療（以下簡稱“豐凱”）完成了B輪融資。本輪融資由君聯資本領投，跟投方包括辰德資本、賽富基金、成為創伴以及凱風創投，老股東禮來亞洲基金、開泰投資持續加碼。 more info >> |
|
|
Legend Capital leads ForQaly Medical's Series B financing |
| ForQaly Medical (hereinafter referred to as "ForQaly"), located in Shanghai Zhangjiang International Medical Zone, is a leading high-tech company focused on developing micro-traumatic circulatory assistant devices. more info >> |
|
| Monday, September 27, 2021 |
|
|
君联资本物流供应链投资进入收获期 |
| 近年来，物流行业频频迎来重大资本事件，快运、供应链、货运平台、航空物流、自动驾驶等多个领域都迎来上市潮。 more info >> |
|
|
君聯資本物流供應鏈投資進入收穫期 |
| 近年來，物流行業頻頻迎來重大資本事件，快運、供應鏈、貨運平台、航空物流、自動駕駛等多個領域都迎來上市潮。 more info >> |
|
|
Legend Capital is reaping the rewards in its logistics and supply chain investment |
| In recent years, the logistics and supply chain industry has ushered in many important capital events, with a lot of companies went public in fields like express, supply chain, freight platform, aviation logistics and automatic driving. more info >> |
|
| Tuesday, September 14, 2021 |
|
|
Legend Capital Led a New Round of Investment of Etana |
| Legend Capital led a new round of investment of PT Etana Biotechnologies Indonesia (Etana), along with Innovent Biologics, Inc. (Innovent) (HKEX: 01801), and a consortium led by UOB Venture Management (UOBVM). more info >> |
|
| Friday, September 10, 2021 |
|
|
君联资本上半年收获4个MedTech IPO：深耕长线，聚焦创新 |
| 近日，中国专注于肿瘤全病程管理的基因检测公司“和瑞基因”宣布完成人民币近7亿元B1轮融资，获君联资本持续加持，另有招商局资本领投，启明创投持续加持，中金启辰、易方达资本、福建创新投资、建发新兴投资等知名投资机构跟投。 more info >> |
|
|
君聯資本上半年收穫4個MedTech IPO：深耕長線，聚焦創新 |
| 近日，中國專注於腫瘤全病程管理的基因檢測公司“和瑞基因”宣佈完成人民幣近7億元B1輪融資，獲君聯資本持續加持，另有招商局資本領投，啟明創投持續加持，中金啟辰、易方達資本、福建創新投資、建發新興投資等知名投資機構跟投。 more info >> |
|
|
Legend Capital enjoys 4 MedTech IPOs in 1H2021, focusing on long-term and innovation investment |
| Recently, Berry Oncology, a company focusing on genomic testing of cancers in China, announced the completion of a US$99.15 million Series B1 financing round, with Legend Capital's continuous support. more info >> |
|
|
|
|
